Trial
NCT05769959
Study of RO7515629 in Participants With HLA-G Positive Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Hoffmann-La Roche
Collaborators
—
Condition
Renal Cell Carcinoma
Intervention
RO7515629
Why stopped
Sponsor decision (not related to safety, efficacy or quality).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-09